AstraZeneca

Investors mostly look for famous stocks within the FTSE 100, but in 2024, it’s about tuning into sectors and companies quietly repositioning themselves. Some have been around for decades and have reinvented themselves. In this rapidly evolving economic landscape, long-standing names are transforming while newcomers make waves. Here’s a glance at a handful of stocks that might not scream attention but are on the verge of significant breakthroughs. Diageo (DGE): A Classic with a Twist Diageo has always been a cornerstone of consumer stocks, but its appeal in 2024 runs deeper. Luxury brands within its portfolio, like Johnnie Walker Blue Label and Don Julio, are in tune with consumer preferences. Diageo’s growing footprint in markets such as Asia, where the demand for premiumization is just taking off. This stock is tapping into emerging luxury consumer trends. AstraZeneca (AZN): Science Leading the Charge AstraZeneca is an essential pharmaceutical player, but 2024 brings it into sharper focus due to its strong push in oncology and respiratory treatments, breakthroughs in cancer therapies, and the broadening accessibility of its treatments in new markets. Investors are watching closely as AstraZeneca's innovations could lead to larger market dominance fueled by steady demand for specialised healthcare solutions. Glencore (GLEN): Riding the Commodities Surge With the demand for renewable energy and electric vehicles intensifying, the need for metals like copper, cobalt, and lithium—resources Glencore has in abundance. The company’s aggressive adaptation toward responsible sourcing and sustainability initiatives is designed to appeal to ESG-focused investors. Glencore has a diverse portfolio of commodities and a strategic global presence at the crossroads of industrial demand and green energy-momentum. Unilever (ULVR): Recession-Proof and Sustainability Savvy Unilever might feel like a staple in any portfolio, but it’s quietly aligning itself with the future. The company’s focus on eco-friendly product lines will attract new investor attention in 2024. Its consistent performance makes Unilever a solid defensive stock. Don’t overlook its steady innovation in health-conscious and environmentally friendly products—these could drive growth beyond its defensive charm. Legal & General (LGEN): Insurance with a Vision With financial stability being a critical concern heading into 2024, Legal & General’s performance is worth attention. The company isn’t just about insurance presence in pension fund management, and infrastructure investment sets it apart. Investors looking for diversification will find this stock’s focus on long-term projects particularly appealing. The Bigger Picture for 2024 As 2024 unfolds, Investors should stop sticking to the tried-and-tested stocks and expand their portfolios. The best FTSE 100 stocks are the ones quietly transforming their business models, addressing not just today’s challenges but also positioning for future demands. Whether it's Unilever’s sustainability drive, Glencore’s focus on green energy metals, or Diageo’s premium spirits strategy, these stocks show that reinvention is critical to thriving in the coming year. Read about more stocks here.

AstraZeneca

Best FTSE Stocks for 2024: Top Picks for Growth and Stability

AstraZeneca Share Price Prediction: Read Before Buying

AstraZeneca Share Price Analysis: Is Growth Imminent?

AstraZeneca Share Price Has Dipped. Is it Safe to Buy AZN Stock?

AstraZeneca Share Price: How Innovation is Pushing AZN UP